AMEX · Financial Statements

Neuraxis, Inc. (NRXS) Financial Statements

$7.40 AMEX: NRXS Market Cap $92.93M

Neuraxis, Inc. most recently reported annual revenue of $4.0M, a net loss of $8.0M. Revenue grew at an average annual rate of 14.9% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Neuraxis, Inc.: Revenue rose from $2.0M in 2020 to $4.0M in 2025, a change of +100.0% over 5 years; net profit was positive in 0 of 6 reported years; operating margin moved from -213.5% to -219.4%, a shift of -5.9 percentage points; the most recent year shows a net loss of $8.0M.

Income Statement — 6 Years (USD millions)

Metric202020212022202320242025
Revenue$2.0M$3.0M$3.0M$2.0M$3.0M$4.0M
Operating Expenses$6.0M$6.0M$6.0M$9.0M$10.0M$11.0M
Operating Profit$-4.0M$-3.0M$-3.0M$-7.0M$-7.0M$-8.0M
Operating Margin-213.5%-109.1%-125.6%-270.9%-266.5%-219.4%
Other Income$0$0$-1.0M$-8.0M$-1.0M$0
Interest$0$0$0$5.0M$0$0
Depreciation$0$0$0$0$0$0
Profit Before Tax$-4.0M$-3.0M$-5.0M$-15.0M$-8.0M$-8.0M
Tax$0$0$0$0$0$0
Net Profit$-4.0M$-3.0M$-5.0M$-15.0M$-8.0M$-8.0M
EPS$-0.80$-0.62$-0.78$-2.32$-1.22$-0.95
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

7 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$0$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$2.0M$2.0M
Operating Expenses$3.0M$2.0M$2.0M$3.0M$2.0M$2.0M$3.0M$3.0M$3.0M$3.0M$3.0M$4.0M
Operating Profit$-3.0M$-2.0M$-2.0M$-2.0M$-2.0M$-1.0M$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M
Operating Margin-633.0%-305.4%-283.3%-360.9%-247.7%-192.7%-256.3%-192.1%-258.8%-177.3%-108.3%-110.2%
Interest$1.0M$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-9.0M$-5.0M$-2.0M$-3.0M$-2.0M$-1.0M$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-9.0M$-5.0M$-2.0M$-3.0M$-2.0M$-1.0M$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M$-2.0M
EPS$-1.40$-0.84$-0.32$-0.42$-0.25$-0.24$-0.33$-0.22$-0.24$-0.16$-0.18$-0.19

Over the 6 years reported for Neuraxis, Inc., cash stood at $5.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.00 times.

Balance Sheet — 6 Years (USD millions)

Metric202020212022202320242025
Total Assets$3.0M$1.0M$1.0M$1.0M$5.0M$6.0M
Current Assets$2.0M$0$0$0$4.0M$6.0M
Cash$2.0M$0$0$0$4.0M$5.0M
Inventory$0$0$0$0$0$0
Receivables$0$0$0$0$0$0
Fixed Assets$0$0$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0
Investments$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0
Total Liabilities$1.0M$2.0M$7.0M$2.0M$3.0M$3.0M
Current Liabilities$1.0M$1.0M$7.0M$2.0M$2.0M$3.0M
Borrowings$0$0$1.0M$0$0$0
Other Liabilities$1.0M$1.0M$6.0M$2.0M$2.0M$3.0M
Equity$0$0$0$0$0$0
Reserves$2.0M$-1.0M$-6.0M$-1.0M$2.0M$3.0M

For Neuraxis, Inc., operating cash flow was positive in 0 of 6 reported years; free cash flow in the latest year was negative at $6.0M; free cash flow was positive in 0 of 6 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 6 Years (USD millions)

Metric202020212022202320242025
Operating Cash Flow$-4.0M$-2.0M$-2.0M$-7.0M$-6.0M$-6.0M
Investing Cash Flow$0$0$0$0$0$0
Financing Cash Flow$3.0M$-1.0M$-1.0M$0$0$-1.0M
Net Cash Flow$2.0M$-2.0M$0$0$4.0M$1.0M
Free Cash Flow$-4.0M$-2.0M$-2.0M$-7.0M$-6.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.30
EV / EBITDA-10.82
FCF Yield-6.31%
Quick Ratio2.95
Interest Coverage-148.01
Return 1Y185.13%
Return 3Y—
Return 5Y—

Neuraxis, Inc. (NRXS) financials — frequently asked questions

What is Neuraxis, Inc.'s annual revenue?

Neuraxis, Inc. (NRXS) reported annual revenue of $4.0M in its most recent fiscal year.

What is Neuraxis, Inc.'s net profit?

Neuraxis, Inc. (NRXS) reported a net loss of $8.0M in its most recent fiscal year.

What is NRXS EV/EBITDA?

Neuraxis, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -10.82. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
NRXS Overview NRXS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.